Post-thrombotic syndrome is common after deep-vein thrombosis and can cause severe symptoms involving the limbs that impair patients’ activity and quality of life. Endovascular therapy can ...

In dementia care relying only on randomized controlled trials can leave out a large amount of strong research that reflects ...

The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because ...

KEYMAKER-U01E: A phase 2 umbrella study with rolling arms of investigational agents with or without chemotherapy plus pembrolizumab for resectable stage II–IIIB (N2) non–small-cell lung cancer (NSCLC) ...

A systematic review finds limited evidence that selected drugs and hydration may reduce the risk for kidney stone recurrence.

SALVOVAR: A pragmatic randomized phase III trial comparing the salvage weekly dose-dense regimen to the standard 3-weekly regimen in patients with poor prognostic ovarian cancers (GINECO-OV130b; ENGOT ...

A recent randomized clinical trial has found that men with localized, intermediate-risk prostate cancer recovered faster and ...

Three-fourths of patients have 70-75% improvement at 16 weeks with zasocitinib, envudeucit ...

Pancreatic cancer is one of the deadliest cancers and among the hardest to treat, with most patients surviving less than a ...

A randomized trial conducted by the Alliance for Clinical Trials in Oncology with support from the National Cancer Institute has found that duloxetine, a medication commonly used to treat chronic pain ...